Frusemide Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 50 mg/ml
Reference Brands: Lasix (India/EU), Frusid (LATAM)
Category:
Heart Disorder
Furosemide is used in dogs and cats to promote diuresis and manage fluid retention. It is commonly used to treat pulmonary edema due to CHF. Other uses include diuresis in acute renal failure, management of ascites, hypercalcemia, or hyperkalemia.
Frusemide Injection is available in Injection
and strengths such as 50 mg/ml.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Frusemide Injection is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Frusemide Injection can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Frusemide injection is a potent loop diuretic widely used in animals to manage fluid retention and related cardiovascular conditions. It is commonly prescribed for the treatment of edema associated with congestive heart failure, pulmonary edema, ascites, and other disorders causing excessive fluid accumulation. By promoting the excretion of sodium, chloride, and water through the kidneys, frusemide helps reduce swelling and improves cardiovascular and renal function.
The mechanism of action involves inhibition of sodium and chloride reabsorption in the ascending limb of the loop of Henle, leading to increased urine output and rapid relief from fluid overload. The injectable formulation allows for precise and fast-acting therapy, especially in acute conditions where oral administration is not feasible.
Frusemide injection is typically administered via intravenous (IV) or intramuscular (IM) routes, with dosage carefully adjusted according to the animal species, weight, and severity of the condition. Its effectiveness, rapid onset, and versatility make it an essential tool for managing cardiovascular and fluid-related disorders in veterinary practice. Proper monitoring is recommended to prevent potential side effects such as electrolyte imbalance or dehydration.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing